Lifeward LTD Form 4 insider transactions

Lifeward Ltd. Chief Medical Officer Keith Dale reports acquisition of 15,000 ordinary shares via vesting of restricted stock units.

Lifeward Ltd. Director William Mark Sigsbee acquired 11,485 ordinary shares through the vesting of restricted stock units.

Moshe H. Rozenbaum, a Director at Lifeward Ltd., reported the acquisition of 11,485 ordinary shares through the vesting of restricted stock units.

Lifeward Ltd.'s Chief Financial Officer, Almog Adar, was granted 39,934 stock options with an exercise price of $6.53, vesting over four years.

Lifeward Ltd. President and CEO, William Mark Grant, was granted options to purchase 172,698 ordinary shares at an exercise price of $6.53.

Lifeward Ltd. Director Yehuda Reznick was granted 7,657 restricted stock units, aligning his interests with shareholders.

Lifeward Ltd. Director Nadav Kidron was granted 7,657 restricted stock units, vesting quarterly over one year.

Lifeward Ltd. Director Miriam Kidron received a grant of 7,657 restricted stock units, aligning her interests with shareholders.

Lifeward Ltd.'s VP of Market Access & Strategy, Jeannine Lynch, was granted 50,000 restricted stock units vesting over four years.

Lifeward Ltd.'s VP of Market Access & Strategy, Jeannine Lynch, sold 1,591 ordinary shares at $0.64 each to cover tax withholding obligations from RSU vesting.

Lifeward Ltd.'s Chief Financial Officer, Almog Adar, was granted 225,000 stock options under the company's 2025 Incentive Compensation Plan.

Lifeward Ltd. Director Randel Richner was granted 35,920 restricted stock units, vesting quarterly, under the company's 2025 Incentive Compensation Plan.

Lifeward Ltd. Director Hadar Levy was granted 35,920 restricted stock units under the company's 2025 Incentive Compensation Plan.

Lifeward Ltd. Director Joseph E. Turk Jr. reported the acquisition of 71,839 ordinary shares through a restricted stock unit grant and the disposition of 18,516 shares from an ESOP.

Lifeward Ltd. Director John William Poduska Sr. was granted 35,920 restricted stock units, vesting quarterly starting three months after the August 1, 2025 grant date.

Lifeward Ltd. Director Robert J. Marshall Jr. was granted 35,920 restricted stock units under the company's 2025 Incentive Compensation Plan.

Lifeward Ltd. director Michael Swinford was granted 35,920 restricted stock units under the company's 2025 Incentive Compensation Plan.

Lifeward Ltd.'s President and Co-CEO, William Mark Grant, was granted 400,000 stock options with a vesting schedule tied to continued service, as disclosed in a recent SEC Form 4 filing.

CEO Lawrence Jasinski sold 1,909 ordinary shares of Lifeward Ltd. to cover tax obligations related to vesting restricted stock units.

Lind Global Fund II LP, a 10% owner of Lifeward Ltd., has reported multiple transactions involving the sale of ordinary shares between January 6th and January 7th, 2025, resulting in a decreased beneficial ownership.

Director Randel Richner sold 4,285 ordinary shares of Lifeward Ltd. in the open market on December 13, 2024.

Lifeward Ltd. director Joseph E. Turk Jr. purchased 6,000 ordinary shares in the open market at a price of $1.69 per share on December 13, 2024.

Lifeward Ltd. director Michael Swinford purchased 21,622 ordinary shares at a weighted average price of $2.0284 per share.

Lifeward Ltd. director Michael Swinford purchased 16,907 ordinary shares at an average price of $1.8276 per share on November 22, 2024.

Director Michael Swinford of Lifeward Ltd. purchased 16,471 ordinary shares at an average price of $1.8354 per share.

CEO Lawrence Jasinski sold 2,672 ordinary shares of Lifeward Ltd. to cover tax obligations related to vesting restricted stock units.

Jeannine Lynch, VP of Market Access & Strategy at ReWalk Robotics, sold shares to cover tax obligations related to vesting restricted stock units.

ReWalk Robotics CEO Lawrence Jasinski sold 2,665 ordinary shares on August 2, 2024, to cover tax obligations related to vesting restricted stock units.

Jeannine Lynch, VP of Market Access & Strategy at ReWalk Robotics, sold 1,783 ordinary shares to cover tax obligations related to vesting restricted stock units.

Jeannine Lynch, VP of Market Access & Strategy at ReWalk Robotics, sold shares to cover tax obligations related to vesting restricted stock units.